Abstract |
Stroke is a major cause of death worldwide and the leading cause of permanent disability. Although reperfusion is currently used as treatment, the restoration of blood flow following ischaemia elicits a profound inflammatory response mediated by proinflammatory cytokines such as tumour necrosis factor (TNF), exacerbating tissue damage and worsening the outcomes for stroke patients. Phosphoinositide 3-kinase delta (PI3Kδ) controls intracellular TNF trafficking in macrophages and therefore represents a prospective target to limit neuroinflammation. Here we show that PI3Kδ inhibition confers protection in ischaemia/reperfusion models of stroke. In vitro, restoration of glucose supply following an episode of glucose deprivation potentiates TNF secretion from primary microglia-an effect that is sensitive to PI3Kδ inhibition. In vivo, transient middle cerebral artery occlusion and reperfusion in kinase-dead PI3Kδ (p110δ(D910A/D910A)) or wild-type mice pre- or post-treated with the PI3Kδ inhibitor CAL-101, leads to reduced TNF levels, decreased leukocyte infiltration, reduced infarct size and improved functional outcome. These data identify PI3Kδ as a potential therapeutic target in ischaemic stroke.
|
Authors | Pei Ching Low, Silvia Manzanero, Nika Mohannak, Vinod K Narayana, Tam H Nguyen, David Kvaskoff, Faith H Brennan, Marc J Ruitenberg, Mathias Gelderblom, Tim Magnus, Hyun Ah Kim, Brad R S Broughton, Christopher G Sobey, Bart Vanhaesebroeck, Jennifer L Stow, Thiruma V Arumugam, Frédéric A Meunier |
Journal | Nature communications
(Nat Commun)
Vol. 5
Pg. 3450
(Mar 14 2014)
ISSN: 2041-1723 [Electronic] England |
PMID | 24625684
(Publication Type: Journal Article)
|
Chemical References |
- Tumor Necrosis Factor-alpha
- Class I Phosphatidylinositol 3-Kinases
- Pik3cd protein, mouse
|
Topics |
- Animals
- Class I Phosphatidylinositol 3-Kinases
- Disease Models, Animal
- Inflammation
(metabolism)
- Male
- Mice
- Phosphatidylinositol 3-Kinases
(metabolism)
- Stroke
(enzymology, metabolism)
- Tumor Necrosis Factor-alpha
(metabolism)
|